Report date: Jan 27,2026
Conflict count: 370687
Publisher: Elsevier
Title count: 959
Conflict count: 17920


==========================================================

Created: 2020-10-31 07:03:13
ConfID: 5737357
CauseID: 1480997923
OtherID: 1480997922
JT: Hematology Transfusion and Cell Therapy
MD: Miranda,42,,500,2020,RELATO DE EXPERIÊNCIA DE UMA VIVÊNCIA EM ESTÁGIO DE UMA LIGA ACADÊMICA
DOI: 10.1016/j.htct.2020.10.845(Journal) (5737357-N)
DOI: 10.1016/j.htct.2020.10.844(Journal)
==========================================================

Created: 2020-10-31 06:41:08
ConfID: 5737356
CauseID: 1480996469
OtherID: 1480996470
JT: Hematology Transfusion and Cell Therapy
MD: Perruso,42,,30,2020,ANEMIA HEMOLÍTICA AUTOIMUNE DURANTE HEMODIÁLISE: UMA APRESENTAÇÃO RARA DA DOENÇA DAS CRIOAGLUTININAS
DOI: 10.1016/j.htct.2020.10.049(Journal) (5737356-N)
DOI: 10.1016/j.htct.2020.10.050(Journal)
==========================================================

Created: 2025-11-11 07:35:16
ConfID: 8442696
CauseID: 1720714939
OtherID: 1480997213
JT: Hematology Transfusion and Cell Therapy
MD: Crusoé,42,,273,2020,PRELIMINARY RESULTS OF DARATUMUMAB, CYCLOPHOSPHAMIDE, THALIDOMIDE AND DEXAMETHASONE: A QUADRUPLET INTENSIED TREATMENT FOR NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) TRANSPLANT ELIGIBLE (TE) PATIENTS
DOI: 10.1016/j.htct.2020.10.456(Journal) (8442696-N)
DOI: 10.1016/j.htct.2020.10.455(Journal)